Latest News & Updates | Lymphoma Canada Announcements

News

Health Canada Approves ADCETRIS® (Brentuximab Vedotin) for the Post-ASCT Consolidation Treatment of Patients with Hodgkin Lymphoma at Increased Risk of Relapse or Progression

Health Canada Approves ADCETRIS® (Brentuximab Vedotin) for the Post-ASCT Consolidation Treatment of Patients with Hodgkin…

adminJuly 26, 2017

Events News

Lymphoma Canada Awareness Day at Queen’s Park

Lymphoma Canada Awareness Day at Queen's Park Cocktail reception 5:00 p.m. – 7:00 p.m. Guests must…

adminJuly 19, 2017

News

New Targeted Therapy Safe and Effective in Refractory Non-Hodgkin’s Lymphoma Patients

Treatment with a new targeted therapy, duvelisib, has shown sustained efficacy and safety in a…

adminJuly 7, 2017

News

New Targeted Therapy Safe and Effective in Refractory Non-Hodgkin’s Lymphoma Patients

Treatment with a new targeted therapy, duvelisib, has shown sustained efficacy and safety in a…

adminJuly 7, 2017

News

Manitoba Leads the Way in CLL Research and Treatment

Recently, a group of Manitoba CLL experts formed the Integrated Multidisciplinary CLL Research Cluster –…

adminJuly 7, 2017

News

Hodgkin Lymphoma Patient, Survivor & Caregiver Surveys

If you have or had Hodgkin lymphoma or you are or were a caregiver of…

adminJune 5, 2017

Events News

Living Well with CLL in Montreal

Living Well with CLL in Montreal Chronic Lymphocytic Leukemia Connection Group Seeking to meet the…

adminJune 5, 2017

News

CLL & SLL Patient & Caregiver Surveys

If you have chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) or you…

adminMay 25, 2017

News

CAR-T Cell Therapy Shows Promise in Aggressive NHL

Promising results from the phase 1 portion of a multi-center phase 1/2 clinical trial (ZUMA-1…

adminApril 4, 2017

News

Pembrolizumab may help those with relapsed NK-cell and T-cell lymphomas

A small study suggests that pembrolizumab may provide lasting remissions in some patients with NK-cell…

adminApril 4, 2017

Mon	Tue	Wed	Thu	Fri	Sat	Sun
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

News & Media

Health Canada Approves ADCETRIS® (Brentuximab Vedotin) for the Post-ASCT Consolidation Treatment of Patients with Hodgkin Lymphoma at Increased Risk of Relapse or Progression

Lymphoma Canada Awareness Day at Queen’s Park

New Targeted Therapy Safe and Effective in Refractory Non-Hodgkin’s Lymphoma Patients

New Targeted Therapy Safe and Effective in Refractory Non-Hodgkin’s Lymphoma Patients

Manitoba Leads the Way in CLL Research and Treatment

Hodgkin Lymphoma Patient, Survivor & Caregiver Surveys

Living Well with CLL in Montreal

CLL & SLL Patient & Caregiver Surveys

CAR-T Cell Therapy Shows Promise in Aggressive NHL

Pembrolizumab may help those with relapsed NK-cell and T-cell lymphomas

Are you a patient?

Are you a healthcare professional?

Upcoming Events

Contact Us

Donate

Careers

Join Our Mailing List